UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Plasma cell myeloma in a patient with Gaucher disease

Blood, 2019-01, Vol.133 (1), p.100-100

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of liver-directed, adeno-associated vector-mediated gene therapy in the canine model of hemophilia A

Blood, 2022-12, Vol.140 (25), p.2672-2683

2022

Link zum Volltext

Verfügbarkeit prüfen

The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study

Blood, 2007-01, Vol.109 (1), p.145-154

2007

Link zum Volltext

Verfügbarkeit prüfen

High Dose Methotrexate Does Not Reduce the Risk of CNS Relapse in Children and Young Adults with Acute Lymphoblastic Leukaemia and Lymphoblastic Lymphoma. Results of the Randomised Phase III Study UKALL 2011

Blood, 2022-11, Vol.140 (Supplement 1), p.516-518

2022

Link zum Volltext

Verfügbarkeit prüfen

Major Deviations in the Delivery of Induction Chemotherapy Are Associated with an Increased Risk of Relapse in Acute Lymphoblastic Leukaemia: Results from UKALL2003

Blood, 2019-11, Vol.134 (Supplement_1), p.2579-2579

2019

Link zum Volltext

Verfügbarkeit prüfen

CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL

Blood, 2024-01, Vol.143 (2), p.118

2024

Link zum Volltext

Verfügbarkeit prüfen

Clonal Dynamics of Early Responder and Long-Term Surviving CAR-T Cells in Humans

Blood, 2019-11, Vol.134 (Supplement_1), p.52-52

2019

Link zum Volltext

Verfügbarkeit prüfen

SSBP2-CSF1R is a recurrent fusion in B-lineage acute lymphoblastic leukemia with diverse genetic presentation and variable outcome

Blood, 2021-04, Vol.137 (13), p.1835-1838

2021

Link zum Volltext

Verfügbarkeit prüfen

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning

Blood, 2010-06, Vol.115 (25), p.5147-5153

2010

Link zum Volltext

Verfügbarkeit prüfen

Dual Antigen Targeting with Co-Transduced CD19/22 CAR T Cells May Prevent Antigen-Negative Relapse after CAR T Cell Therapy for Relapsed/Refractory ALL

Blood, 2022-11, Vol.140 (Supplement 1), p.10352-10354

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of AUTO3, a Bicistronic Chimeric Antigen Receptor (CAR) T-Cell Therapy Targeting CD19 and CD22, in Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-ALL): Amelia Study

Blood, 2019-11, Vol.134 (Supplement_1), p.2620-2620

2019

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Response in Patients Receiving CD34-Selected Stem Cell Infusions without Conditioning to Correct Graft Failure Following Allogeneic Stem Cell Transplantation

Blood, 2018-11, Vol.132 (Supplement 1), p.204-204

2018

Link zum Volltext

Verfügbarkeit prüfen

Dexamethasone Pharmacokinetics Following Standard and Short Dosing Schedules in Patients on the UKALL2011 Trial

Blood, 2017-12, Vol.130, p.101-101

2017

Link zum Volltext

Verfügbarkeit prüfen

Cord Blood Transplantation in Adolescents and Young Adults with Acute Leukemia: On Behalf of Eurocord, Ctiwp and PDWP of EBMT

Blood, 2018-11, Vol.132 (Supplement 1), p.3369-3369

2018

Link zum Volltext

Verfügbarkeit prüfen

Therapy of Paediatric B-ALL with a Fast Off Rate CD19 CAR Leads to Enhanced Expansion and Prolonged CAR T Cell Persistence in Patients with Low Bone Marrow Tumour Burden, and Is Associated with a Favourable Toxicity Profile

Blood, 2019-11, Vol.134 (Supplement_1), p.225-225

2019

Link zum Volltext

Verfügbarkeit prüfen

Relapse in Teenage and Young Adult (TYA) Patients Treated on a Pediatric Minimal Residual Disease (MRD) Stratified Protocol Is Associated with a Poor Outcome: Results from UKALL2003

Blood, 2015-12, Vol.126 (23), p.2493-2493

2015

Link zum Volltext

Verfügbarkeit prüfen

Use of Morphological Early Response Data to Predict Relapse in Teenage and Young Adult (TYA) Patients with Acute Lymphoblastic Leukaemia (ALL)

Blood, 2015-12, Vol.126 (23), p.1415-1415

2015

Link zum Volltext

Verfügbarkeit prüfen

Improved Outcome for Children and Young People with T-Acute Lymphoblastic Leukaemia: Results of the UKALL 2003 Trial

Blood, 2014-12, Vol.124 (21), p.3702-3702

2014

Link zum Volltext

Verfügbarkeit prüfen

Outcomes Of Teenagers and Young Adults On The UKALL 2003 Paediatric Trial For Children and Young People With Acute Lymphoblastic Leukaemia

Blood, 2013-11, Vol.122 (21), p.57-57

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact Of Age On Toxicity Associated With Chemotherapy For Acute Lymphoblastic Leukaemia (ALL): Results From The UK Prospective Study UKALL2003

Blood, 2013-11, Vol.122 (21), p.840-840

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink

Zeitschrift / SerieBlood

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(44)

Sprache

Englisch
(45)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Hematology
(10)
Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Humans
(7)
Male
(6)
Biological And Medical Sciences
(5)
Female
(5)
Hematologic And Hematopoietic Diseases
(4)
Medical Sciences
(4)
Adolescent
(3)
Biochemistry
(3)
Cell Biology
(3)
Child
(3)
Immunology
(3)
Middle Aged
(3)
Adult
(2)
Aged
(2)
Amino Acid Substitution
(2)
Animals
(2)
Canada - Epidemiology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

Plasma cell myeloma in a patient with Gaucher disease

Long-term follow-up of liver-directed, adeno-associated vector-mediated gene therapy in the canine model of hemophilia A

The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study

A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia

High Dose Methotrexate Does Not Reduce the Risk of CNS Relapse in Children and Young Adults with Acute Lymphoblastic Leukaemia and Lymphoblastic Lymphoma. Results of the Randomised Phase III Study UKALL 2011

Major Deviations in the Delivery of Induction Chemotherapy Are Associated with an Increased Risk of Relapse in Acute Lymphoblastic Leukaemia: Results from UKALL2003

CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL

Clonal Dynamics of Early Responder and Long-Term Surviving CAR-T Cells in Humans

SSBP2-CSF1R is a recurrent fusion in B-lineage acute lymphoblastic leukemia with diverse genetic presentation and variable outcome

Systematic Intention to Treat Analysis of Real-World Outcomes in Children and Young Adults Receiving Tisagenlecleucel: From Elegibility through Treatment Failure

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning

Dual Antigen Targeting with Co-Transduced CD19/22 CAR T Cells May Prevent Antigen-Negative Relapse after CAR T Cell Therapy for Relapsed/Refractory ALL

Phase I Study of AUTO3, a Bicistronic Chimeric Antigen Receptor (CAR) T-Cell Therapy Targeting CD19 and CD22, in Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-ALL): Amelia Study

Predictors of Response in Patients Receiving CD34-Selected Stem Cell Infusions without Conditioning to Correct Graft Failure Following Allogeneic Stem Cell Transplantation

Intention to Treat Analysis of Real-World Outcomes Following Tisgenlecleucel Therapy for Pediatric and Young Adult ALL through a National Access Programme

Dexamethasone Pharmacokinetics Following Standard and Short Dosing Schedules in Patients on the UKALL2011 Trial

Cord Blood Transplantation in Adolescents and Young Adults with Acute Leukemia: On Behalf of Eurocord, Ctiwp and PDWP of EBMT

Simultaneous Targeting of CD19 and CD22: Phase I Study of AUTO3, a Bicistronic Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-ALL): Amelia Study

Therapy of Paediatric B-ALL with a Fast Off Rate CD19 CAR Leads to Enhanced Expansion and Prolonged CAR T Cell Persistence in Patients with Low Bone Marrow Tumour Burden, and Is Associated with a Favourable Toxicity Profile

Relapse in Teenage and Young Adult (TYA) Patients Treated on a Pediatric Minimal Residual Disease (MRD) Stratified Protocol Is Associated with a Poor Outcome: Results from UKALL2003

Use of Morphological Early Response Data to Predict Relapse in Teenage and Young Adult (TYA) Patients with Acute Lymphoblastic Leukaemia (ALL)

In Vivo Assessment of Intracellular Dynamics Comparing Injection Versus Oral Azacitidine in a Phase IIb Investigator Initiated Clinical Trial

Improved Outcome for Children and Young People with T-Acute Lymphoblastic Leukaemia: Results of the UKALL 2003 Trial

Outcomes Of Teenagers and Young Adults On The UKALL 2003 Paediatric Trial For Children and Young People With Acute Lymphoblastic Leukaemia

Impact Of Age On Toxicity Associated With Chemotherapy For Acute Lymphoblastic Leukaemia (ALL): Results From The UK Prospective Study UKALL2003

Aktive Filter

Suchergebnisse filtern